Gayer Charles K - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 13, 2024, Gayer Charles K's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Officer (Chief Commercial Officer), and currently has 307,533 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCRX insiders.
Data Source: SEC.
Gayer Charles K - Insider Non-Derivative Transactions of BCRX Common Stock
Gayer Charles K - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 14, 2024 | P -- (Common Stock) | 30000 | 5.47 | 307533 |
| Dec 20, 2023 | F -- (Common Stock) | 2482 | 6.05 | 274533 |
| Dec 15, 2023 | F -- (Common Stock) | 5840 | 6.43 | 277015 |
| Dec 15, 2023 | Acquisition -- (Common Stock) | 34000 | 0 | 282855 |